Research Center for Respiratory Pathogens Established at Lung Research Medical Center Through $4.7M Grant
University of Rochester Medical Center Establishes New Respiratory Pathogens Research Center
The University of Rochester Medical Center (URMC) has announced the creation of the Respiratory Pathogens Research Center, a groundbreaking initiative aimed at advancing our understanding of respiratory viruses and their impact on various populations. The center, led by microbiologist David Topham, Ph.D., an influenza researcher, will focus on dissecting immune responses to viruses like Respiratory Syncytial Virus (RSV) and human metapneumovirus (HMPV), with a particular emphasis on vulnerable groups such as older adults, immunocompromised individuals, and premature infants.
The center's research will employ advanced methodologies, including real-time PCR for virus detection, viral serologic analysis for immune response characterization, and sophisticated immunological and genomic techniques to study the effects of infections and environmental factors on lung development and immune function. Key faculty members, such as Dr. Gloria Pryhuber and Dr. Brenda L. Tesini, will contribute their expertise on immune responses and lung inflammation.
The center has secured significant collaborations and funding, including a partnership with the National Institute of Environmental Health Sciences (NIEHS), which supports research on environmental factors affecting respiratory health and aims to translate findings into disease prevention and improved health outcomes. NIEHS’s funding infrastructure fosters multidisciplinary projects that include environmental exposures' role in respiratory morbidity, complementing the center's focus on respiratory pathogens.
The center will also have access to an array of IBM Blue Gene/Q supercomputers for analyzing large amounts of information quickly. This powerful computational resource will enable the center to conduct additional clinical trials of drugs or vaccines for respiratory diseases in children or adults.
The University of Rochester Medical Center team includes a mix of physicians, nurses, researchers, and investigators, with faculty investigators such as Dr. Mary Caserta, Dr. Stephen Gill, Dr. Hulin Wu, Dr. Minsoo Kim, Dr. Andrea Sant, Dr. Thomas Mariani, Dr. Martin Zand, Dr. Mark Sangster, Dr. John Treanor, Dr. Edward Walsh, and Dr. Ann Falsey, an infectious disease specialist and international expert on RSV, contributing their expertise.
The center's potential projects include studies on an experimental vaccine for pneumonia in the elderly, interactions between germs in the body, RSV infections in children, flu vaccines for organ transplant patients, premature infants, and co-infections of viruses and bacteria. The center's research could have far-reaching implications, given that approximately 65 million people in the United States visit doctors or emergency rooms each year with symptoms from respiratory infections, and roughly 2 million children and 4 million people die worldwide each year from acute respiratory infections.
The center's work is supported by a $4.7 million grant from the Federal government and a seven-year agreement with the National Institute of Allergy and Infectious Diseases (NIAID), which could potentially provide up to $50 million in funding over the agreement's duration. In addition, computational informatics scientist Richard Scheuermann, Ph.D., from the University of Texas Southwestern Medical Center in Dallas, will also contribute to the center's research efforts.
The Respiratory Pathogens Research Center at the University of Rochester Medical Center is poised to make significant contributions to vaccine development and our understanding of immune mechanisms underlying respiratory diseases in diverse populations. With its cutting-edge research and collaborative approach, the center aims to protect citizens against bacteria and viruses that cause respiratory infections, ultimately improving health outcomes for millions worldwide.
References: 1. URMC Newsroom: Respiratory Pathogens Research Center 2. URMC Newsroom: URMC Researchers Develop Surfactant Technology to Improve Premature Infant Survival 3. URMC Newsroom: URMC Researchers Contribute to Development of Conjugate Vaccines 4. URMC Newsroom: URMC Researchers Secure $5 Million Grant for Health Research Supercomputer 5. URMC Newsroom: URMC Researchers Contribute to Understanding of Respiratory Diseases in Older Adults
- The Respiratory Pathogens Research Center established at the University of Rochester Medical Center will focus on health research related to various medical-conditions, such as respiratory-conditions, particularly the immune responses to viruses like RSV and HMPV in vulnerable groups like older adults, immunocompromised individuals, and premature infants.
- As part of its research, the center will employ science-based methodologies for virus detection, characterization of immune responses, and the study of environmental factors on lung development and immune function, all with the aim of improving patient care and health-and-wellness.
- The center's multidisciplinary projects, supported by significant funding from institutions like the National Institute of Environmental Health Sciences (NIEHS), aim to conduct clinical trials of drugs or vaccines for respiratory diseases and translate findings into disease prevention and improved health outcomes.
